<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T09:16:23Z</responseDate>
  <request identifier="oai:figshare.com:article/34014192" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34014192</identifier>
        <datestamp>2026-09-28T12:59:58Z</datestamp>
        <setSpec>category_696</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Notoginsenoside R1 modulates the ATF4-CHOP-Bcl2 signaling pathway to alleviate mitochondrial stress damage and apoptosis in asthmatic airway epithelial cells.pdf</dc:title>
          <dc:creator>Yaozheng Ling (14661566)</dc:creator>
          <dc:creator>Ling Guan (7526867)</dc:creator>
          <dc:creator>Yu Zhao (104852)</dc:creator>
          <dc:creator>Zhou Fu (314013)</dc:creator>
          <dc:creator>Wenjing Zou (5720504)</dc:creator>
          <dc:subject>Genetic Immunology</dc:subject>
          <dc:subject>airway epithelial damage</dc:subject>
          <dc:subject>asthma</dc:subject>
          <dc:subject>ATF4-CHOP-Bc2 signaling pathway</dc:subject>
          <dc:subject>mitochondrial stress damage</dc:subject>
          <dc:subject>notoginsenoside R1</dc:subject>
          <dc:description>Objective&lt;p&gt;To investigate whether Notoginsenoside R1 (NG-R1) improves mitochondrial homeostasis by targeting the integrin signaling response (ISR) core transcription factor ATF4, thereby alleviating damage and apoptosis in asthma airway epithelial cells.&lt;/p&gt;Methods&lt;p&gt;House dust mites (HDM) were used to establish an in vivo asthma mouse model and an in vitro BEAS-2B cell model. The anti-inflammatory and immunomodulatory effects of NG-R1 were evaluated through pulmonary function testing, bronchoalveolar lavage fluid (BALF) cell counting, and hematoxylin and eosin (H&amp;E) staining. We evaluated the effects of NG-R1 on apoptosis and mitochondrial function using TUNEL, Annexin V-FITC/PI staining, transmission electron microscopy, MitoSox Red, TMRE, JC-1, and Western blot analysis of mitochondrial dynamics-related proteins (p-Drp1/Drp1, Mfn2, ATP5F1A). We used lentiviral knockdown of ATF4 combined with RNA-seq, GO enrichment analysis, and the STRING database to predict its downstream mechanisms. Molecular docking was used to predict the binding affinity between NG-R1 and ATF4, and the expression levels of ATF4, CHOP, and Bcl-2 were validated using Western blot analysis in both in vivo and in vitro models.&lt;/p&gt;Results&lt;p&gt;ATF4 expression was significantly elevated in lung tissue from asthmatic mice and in HDM-stimulated BEAS-2B cells, and was positively correlated with increased epithelial cell apoptosis and reduced migration and repair capacity. ATF4 knockdown alleviates HDM-induced increases in mitochondrial reactive oxygen species (ROS), decreases in membrane potential, mitochondrial ultrastructural damage, and disbalance in fission/fusion (downregulation of p-Drp1/Drp1 and upregulation of Mfn2 and ATP5F1A) via the ATF4-CHOP-Bcl2 signaling pathway, thereby inhibiting apoptosis. NG-R1 intervention significantly reduced airway hyperresponsiveness, total inflammatory cell counts in BALF, and levels of Th2 cytokines (IL-4, IL-13, IL-33) in asthmatic mice, and alleviated pulmonary inflammatory infiltration. Molecular docking and in vitro and in vivo experiments indicated that NG-R1 may specifically downregulate ATF4 (binding energies of -5.761 and -6.553 kcal/mol, respectively), modulate CHOP-Bcl2 expression levels, improve mitochondrial function and dynamic equilibrium, inhibit epithelial cell apoptosis, and promote migration and repair.&lt;/p&gt;Conclusion&lt;p&gt;NG-R1 may regulate the ATF4-CHOP-Bcl2 signaling pathway by specifically binding to and downregulating ATF4, thereby alleviating mitochondrial stress-induced damage, inhibiting airway epithelial cell apoptosis, and promoting epithelial repair, suggesting that NG-R1 is a potential candidate drug for targeted asthma therapy.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T12:59:58Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fimmu.2026.1861285.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Notoginsenoside_R1_modulates_the_ATF4-CHOP-Bcl2_signaling_pathway_to_alleviate_mitochondrial_stress_damage_and_apoptosis_in_asthmatic_airway_epithelial_cells_pdf/34014192</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
